Medscape18d
Pantoprazole Infusion as Adjuvant Therapy to Endoscopic Treatment in Patients With Peptic Ulcer Bleeding: Prospective Randomized Controlled Trial
Endoscopic therapy is considered the most effective way to stop PUB but the risk of rebleeding is significantly associated with morbidity and mortality. At a low pH, platelet aggregation is ...
Nature2mon
Endoscopic cyanoacrylate therapy for gastric variceal bleeding
Both interventional radiology and endoscopic therapies require a high level of clinical expertise. Which type of therapy is best? A recent study compared endoscopic cyanoacrylate glue injection ...
PharmiWeb9d
Endoscopic Clips Market to Reach $632.5 Mn by 2031…
The global Endoscopic Clips Market is witnessing steady growth, driven by the increasing prevalence of gastrointestinal (GI) ...
FierceBiotech19d
Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets
The updated readout shows duvakitug’s effect on key secondary endpoints and in subgroups of advanced therapy naïve and experienced patients. After 14 weeks, the rates of endoscopic improvement ...
Medindia4d
Vedolizumab Outperforms Infliximab in Second-Line Therapy for Ulcerative Colitis
Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with plans for a Phase 3 trial in 2025.
Medscape12d
Pantoprazole Infusion as Adjuvant Therapy to Endoscopic Treatment in Patients With Peptic Ulcer Bleeding: Prospective Randomized Controlled Trial
The possibility of endoscopic therapy was discussed with the patient and/or their relatives and written informed consent was obtained before the endoscopy. Endoscopic therapy was given if ...